IGF1 and prostate cancer: We have shown that lycopene acts synergistically with docetaxel to reduce the viability of human prostate cancer cells in an insulin‐like growth factor 1 (IGF‐1)‐dependent manner and to enhance the anti‐tumour efficacy of docetaxel in a xenograft mouse model of prostate cancer.27